Folliculitis Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Folliculitis Cream
Generic name: MICONAZOLE NITRATE
Manufacturer: Beautivity LLC
Product type: HUMAN OTC DRUG
SPL set ID: 3155dd5e-621b-358e-e063-6294a90a90f8
SPL ID: 58f42b88-6f07-46fd-e063-6294a90ad08f
Version: 3
Effective date: 2026-08-13
Source export date: 2026-10-30
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/3b4c9bc1c064560160661a043b9878894ba805e5e90f4733fb76824b6ba7ac42/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 19:21:02

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Folliculitis Cream	openfda.brand_name
generic name		MICONAZOLE NITRATE	openfda.generic_name
manufacturer name		Beautivity LLC	openfda.manufacturer_name
ndc	package	85398-001-01	openfda.package_ndc
ndc	product	85398-001	openfda.product_ndc
ndc11	package	85398000101	derived:openfda.package_ndc
rxcui		2712237	openfda.rxcui
spl id		58f42b88-6f07-46fd-e063-6294a90ad08f	id
spl set id		3155dd5e-621b-358e-e063-6294a90a90f8	set_id
unii		VW4H1CYW1K	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only it on children under 2 years of age unless directed by a doctor. avoid contact with eyes. If contact occurs, rinse the eyes thoroughly with water. keep out of the reach of Children. If irritation occurs or there is no improvement within 4 weeks.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.